The Stockholm region introduced an organised prostate cancer testing (OPT) pilot in 2022, where men aged 50 years are offered organised testing using PSA and MRI, with organised retesting and structured follow-up for men with raised test values. Here, KLK3 is linked to Familial prostate cancer.